{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP05136",
    "Peptide Name": "PST11-RK (Synthetic AMPs, Tritrpticin analog, lys-rich, Trp-rich, XXA, UCLL1c)",
    "Source": "amino acid SUBSTITUTION, amino acid deletion, porcine cathelicidin, animal-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KKFPWWWPFKK",
    "Sequence Length": 11,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 5,
    "Boman Index": 0.84,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "45%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is 53.85% similar toTritrpticin. K: 36%, W: 27%, P=F: 18%.Activity: Active against E. coli KCTC 1682 (MIC 4 ug/ml), S. typhimurium KCTC 1926 (MIC 4 ug/ml),  B. subtilis KCTC 3068 (MIC 2 ug/ml), and S. aureus KCTC 1621 or 2 strains MRSA (MIC 2-8 ug/ml), 2 strains vancomycin-resistant E. faecium (MIC 8 ug/ml) anti-VRE. Non-standard assays in 50% LB.MOA: lysed more anionic liposomes than zwitterionic liposomes.In vitro toxicity: human RBC (4%): HC50 >200 uM, less hemo.lytic.",
    "Author": "Yang ST, Shin SY, Hahm KS, Kim JI. 2006",
    "Reference": "Int J Antimicrob Agents. 2006 Apr;27(4):325-30. doi: 10.1016/j.ijantimicag.2005.11.014.PubMed",
    "Title": "Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities."
  },
  "3D Structure": []
}